Russ Jaffe MD, PhD, CCN

Dr. Russell M. Jaffe, worked at the National Institutes of Health (NIH) from 1973 to 1979 where the seeds of his vision began. On leaving NIH Dr. Jaffe began a journey that sought to support the emerging field of Integrative and Regenerative Medicine. His dedication to the application of primary prevention and his commitment to providing superior nutraceuticals and autoimmune testing with clinical evidence of superior efficacy has made him a sought after speaker and leader in his chosen field. In 1984 after, five years of research, Dr. Jaffe invented a process that would eventually lead him to the family of companies he runs today. This innovation’s primary effort was to create a technology platform for measuring and monitoring all delayed allergies in the world’s first single step amplified (ELISA) procedure. When accomplished it was the first performed in a living cell through an advanced culture technique (ACT). Today with over 50,000 cases in the lab database it remains a vibrant part of Dr. Jaffe’s integrated operations. Expanding to Reston, then to Sterling and now to a custom built headquarters and warehouse in Ashburn, Virginia, Dr. Jaffe is continuously expanding and seeking new ways to improve his existing operations while maintaining his production lab, ELISA/ACT® Biotechnologies, his PERQUE nutraceutical plant, and an R&D facility, RMJ Holdings Rx. Dr. Jaffe and his team of highly trained professionals continually look for new ways to help speed the transition from our current healthcare system’s symptom reactive model to a more functionally integrated, effective and compassionate system. PIH is the turnkey outcome of years of Dr. Jaffe’s scientific research. It brings to market two decades of rethinking safer more effective, novel and proprietary dietary supplements, supplement delivery systems, diagnostic testing, and validation studies. In pilot clinical outcomes studies The Alkaline Way Program, utilizing LRA by ELISA/ACT tests for delayed hypersensitivities along with PERQUE supplementation to remove repair deficits, has been confirmed to achieve improvements in common conditions such as diabetes, fibromyalgia muscle pain, and chronic fatigue syndrome (CFIDS). Today, the company creates integrated systems that implement assessment protocols and tools that combine information technology with advanced products for enhanced understanding, compliance and monitoring outcomes. From his humble beginnings in 1984 to today, Dr. Jaffe and his team have steadily moved forward and produced a volume of evidence-based work that has profoundly enhanced functional human nutrition, integrative medicine and proactive preventive healthcare models.